13^th World Congress on Pharmacology and Toxicology November 14-15, 2018 | Mercure Albert Park | Melbourne, Australia

He is currently working as deputy director for Institute of Regenerative Medicine and Biotherapy (IRMB) composed of a 150 persons. He is also a leader of a INSERM research team and Director of a stem cell facility CHU (SAFE-iPSC) comprising more than 33 persons. He is mentoring 8 senior scientists (CR1, MCU, MCU/PH), 11 Ph.D. students and 3 Post-Docs, 9 technicians and engineers. Also he is an invited speaker in 48 national and international conferences and seminars in France and abroad in the last 5 years (3 plenary lectures).

To explore epigenetic mechanisms involved in senescence/aging impairing stem cell renewal and reprogramming, which is of major importance aging with outcomes in regenerative medicine and cell therapies.

Nader G. Abraham is working as professor in Newyork Medical College, Newyork

Pharmacology

Essam Abdel-Sattar is currently working as professor in Cairo University, Egypt

Quality control of drugs

Dr. Yukio Yoneda is a Professor Emeritus in Kanazawa University, where he worked as a Chairman Professor of Pharmacology from 1999 to 2015. He graduated from Osaka University, Faculty of Pharmaceutical Sciences in 1972, followed by appointments in Kyoto Prefectural University of Medicine, City of Hope Research Institute, CA, USA and Setsunan University. He is serving as an Associate Editor in several international journals such as Neurochemistry International, Neurochemical Research and Journal of Neuroscience Research, in addition to acting on the Editorial Board in other international scientific journals. His research interests have been lying on pharmacological profiling of amino acid signaling in neuronal and non-neuronal cells using molecular biological techniques. As a return of laboratory experimental results to the community, he is now attempting to develop several dietary supplements beneficial for the prophylaxis of different diseases besides the bench work with colleagues in domestic and foreign universities.

Molecular pharmacology of amino acid signaling in neuronal and non-neuronal cells

She is currently working as Vice Dean for Academics, Student Affairs, and Cooperation, Postgraduate School, Universitas Padjadjaran, Indonesia. Also she is a professor in the Department of Pharmacology and Clinical Pharmacy in the same university.She is the editor/reviewer of many journals and she has won many awards.

Pharmacology

Stefan Glück, MD, PhD is a Medical Oncologist with focus on solid tumors including brain cancer activities worldwide. Additionally, he is responsible for Immuno-Oncology programs in solid tumors and hematologic diseases and is in the area of Early Assets. He completed his medical studies at the University of West Berlin, Germany in 1978 followed by a medical oncology & bone marrow transplant fellowship in Toronto, Canada. Before becoming V.P. of Global Medical Affairs at Celgene Corp., he previously served as Sylvester Professor of Medicine at the Miller School of Medicine in Miami, Florida until 2014. From 2009-2010 he was Assistant Director of the Sylvester Comprehensive Cancer Center & Associate Chief, for the Division of Hematology & Medical Oncology and from 2003-2008 he served as Clinical Director of the Braman Family Breast Cancer Institute in Miami, Florida. He has authored and co-authored over 260 articles, and has written more than 350 papers at national and international meetings.

Medical Oncology